Search Results 1241-1250 of 15512 for alt

1. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Participation eligibility · Hepatic panel (AST, ALT, total bilirubin) ≤ 2 times ULN; · Estimated CrCl ≥ 40 ml/min as calculated by the CC&G equation; ...

2. Study of bb21217 in Multiple Myeloma - Mayo Clinic

   Inadequate hepatic function defined by AST and/or ALT > 2.5 × upper limit of normal (ULN) and total bilirubin > 1.5 × ULN (unless due to Gilbert's syndrome and ...

3. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   AST/ALT > 3 times the ULN;; Hemoglobin < 10.0 g/dL;; Platelets < 75.0 x 10^9/L;; Albuminemia < 3.0 g/dL. Suspected or documented infectious enterocolitis ...

4. Colesevelam (oral route) - Side effects & dosage - Mayo Clinic

   Colesevelam is used together with proper diet and exercise to lower high cholesterol levels in the blood. This may help prevent medical problems caused by ...

5. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors - Mayo Clinic

   ... [ALT]) < 2.5 times ULN; Patients with seizure disorder if well controlled; Patients who had more than 1 prior surgery/biopsy are eligible. Exclusion Criteria.

6. A Study to Evaluate Gleolan to Enhance Tumor Visualization in Patients with Newly-diagnosed or Recurrent Meningioma - Mayo Clinic

   normal ALT (SGPT) < 2.5 X institutional upper limit of normal Creatinine Below upper limit of normal OR Creatinine clearance >60 mL/min/1.73 m2 for ...

7. Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation - Mayo Clinic

   ... [ALT]) ≤ 2.5 x ULN; Creatinine ≤ 2 x ULN; Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only; Provide ...

8. A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level ≥ 3 timesthe upper limit of normal, confirmed by repeated testing during screening ...

9. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Alanine aminotransferase (ALT) and Aspartate transaminase (AST) 3 x ULN (≤ 5 x ULN for patients with liver involvement);; Calculated creatinine clearance ...

10. ICoN-1 Phase 3 Study Of The Efficacy And Safety Of Treatment With MNKD-101, Clofazimine Inhalation Suspension - Mayo Clinic

    Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >1.5 times upper limit of normal (ULN) or total bilirubin >1.5 times ULN during screening.